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Abstract
The transcriptional state of a cell reflects a variety of biological factors, from persistent cell-type 
specific features to transient processes such as cell cycle. Depending on biological context, all 
such aspects of transcriptional heterogeneity may be of interest, but detecting them from noisy 
single-cell RNA-seq data remains challenging. We developed PAGODA to resolve multiple, 
potentially overlapping aspects of transcriptional heterogeneity by testing gene sets for 
coordinated variability amongst measured cells.
Introduction
Single-cell transcriptome measurements provide an unbiased approach for studying the 
complex cellular compositions inherent to multicellular organisms. Increasingly sensitive 
single-cell RNA-sequencing (scRNA-seq) protocols1,2 have been used to examine both 
healthy and diseased tissues3–14. Nevertheless, analysis of scRNA-seq data remains 
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challenging, as measurements expose numerous differences between cells, only some of 
which may be relevant for system-level functions.
High levels of technical noise15 and strong dependency on expression magnitude pose 
difficulties for principal component analysis (PCA) and other dimensionality reduction 
approaches. Because of this, application of PCA as well as more flexible approaches such as 
GP-LVM16 or tSNE17 is often restricted to highly expressed genes11,12,18. Even when cell-
to-cell variation captures prominent biological processes taking place within the measured 
cells, these processes may not be of primary interest. For example, differences in metabolic 
state or cell cycle phase may be common to multiple cell types, and can mask more subtle 
cell-to-cell variability associated with the biological processes being studied11. Such cross-
cutting transcriptional features represent alternative ways to classify cells, posing a 
challenge for the commonly-used clustering approaches that aim to reconstruct a single 
subpopulation structure5,8,9,11. Partitioning methods, such as k-means clustering or the 
specialized BackSPIN algorithm9 may, for example, choose to classify cells first based on 
the cell cycle phase instead of tissue-specific signaling state, if the cell cycle differences are 
more pronounced.
Here, we describe an alternative approach for analyzing transcriptional heterogeneity called 
PAGODA that aims to detect all statistically-significant ways in which measured cells can be 
classified. PAGODA is based on statistical evaluation of coordinated expression variability 
of previously-annotated pathways as well as automatically-detected gene sets. Gene set 
testing with methods such as GSEA19 has been extensively utilized in the context of 
differential expression analysis to increase statistical power and uncover likely functional 
interpretations. A similar rationale can be applied in the context of heterogeneity analysis. 
For example, while cell-to-cell variability in expression of a single neuronal differentiation 
marker such as Neurod1 may be too noisy and inconclusive, coordinated upregulation of 
many genes associated with neuronal differentiation in the same subset of cells would 
provide a prominent signature distinguishing a subpopulation of differentiating neurons. 
Examining previously published datasets, we illustrate that PAGODA recovers known 
subpopulations and reveals additional subsets of cells in addition to providing important 
insights about the relationships amongst the detected subsets.
The extent of transcriptional diversity in mouse NPCs is likely to be influenced by a variety 
of unexamined factors that include programmed cell death20, genomic mosaicism21–23 as 
well as a variety of “environmental” influences such as changes in exposure to signaling 
lipids24–26. We therefore used scRNA-seq to assess a cohort of cortical NPCs from an 
embryonic mouse. We demonstrate that PAGODA effectively recovers the known 
neuroanatomical and functional organization of NPCs, identifying multiple aspects of 
transcriptional heterogeneity within the developing mouse cortex that are difficult to discern 
by the existing heterogeneity analysis approaches.
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Results
Pathway and Gene Set Overdispersion Analysis (PAGODA)
To characterize significant aspects of transcriptional heterogeneity in a scRNA-seq dataset, 
PAGODA relies on a series of statistical and computational steps (Fig. 1). First, the 
measurement properties of each cell, such as effective sequencing depth, drop-out rate and 
amplification noise are estimated using a previously described mixture model approach27 
with minor enhancements (Step 1, Fig. 1). Using these models, the observed expression 
variance of each gene is renormalized based on the genome-wide variance expectation at the 
appropriate expression magnitude (Step 2). Batch correction is also performed at this stage. 
The resulting residual variance, modeled by the χ2 statistic, effectively distinguishes 
subpopulation-specific genes (Supplementary Notes 1,2), and determines the contribution of 
each gene to the subsequent PCA calculations.
PAGODA then examines an extensive panel of gene sets to identify those showing a 
statistically significant excess of coordinated variability (Step 3). The gene sets include 
annotated pathways, such as Gene Ontology (GO) categories, as well as clusters of 
transcriptionally-correlated genes found within a given dataset (de novo gene sets). The later 
allows PAGODA to detect aspects of transcriptional heterogeneity driven by processes that 
are not represented in the pathway annotation. The prevalent transcriptional signature of 
each gene set is captured by its first principal component (PC), using weighted PCA to 
adjust for technical noise contributions. If the amount of variance explained by the first PC 
of a given gene set is significantly higher than expected (Step 4, correcting for multiple 
hypotheses), the gene set is said to be overdispersed, and is included in the subsequent 
analysis.
The PC of each overdispersed gene set separates cells along a certain axis (PC scores). Many 
PCs will show very similar patterns, either because the same genes drive them, or because 
multiple biological processes distinguish the same subsets of cells. To provide a non-
redundant view of the transcriptional heterogeneity within the dataset, PCs from 
significantly overdispersed gene sets are clustered, and those with similar gene loadings or 
cell separation patterns are combined to form a single 'aspect' of heterogeneity (Step 5, 
Supplementary Fig. 1). The resulting major aspects of transcriptional heterogeneity can be 
explored numerically or through an interactive web browser interface28 (Step 6). As we 
illustrate below, examination of individual aspects and their relationships to each other can 
provide insights and functional clues not apparent from the most prominent cell 
classification. Finally, if upon further interpretation one or more aspects of transcriptional 
heterogeneity are determined to be extraneous to the biological context, PAGODA provides 
an option to control explicitly for such aspects (Step 7).
PAGODA captures alternative annotations of individual cells
To illustrate PAGODA on a complex cell population, we re-examined scRNA-seq data for 
3,005 cells from the mouse cortex and hippocampus from a recent publication by Zeisel et 
al.9. This extensive dataset covers a variety of cell types, some of which exhibit very distinct 
expression signatures. Zeisel et al. also introduced a novel heterogeneity analysis method 
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called BackSPIN9 that performs recursive partitioning. Applying PAGODA revealed nine 
major aspects of heterogeneity that distinguish the seven top-level classes and two lower-
level subpopulations identified by BackSPIN (Fig. 2). The functional interpretation of the 
identified aspects is evident from the identity of overdispersed GO categories. The most 
significant aspect separates oligodendrocytes, the most numerous cell type in the dataset, 
which are easily distinguished by strong overdispersion of myelination-related pathways. 
Similarly, overdispersion of immune, vascular, and muscle-associated GO-annotated gene 
sets identify microglia, vascular endothelial, and mural subpopulations respectively. Other 
cell types, such as ependymal cells, or different types of neurons are distinguished by de 
novo gene set signatures, with most overdispersed genes revealing their identity (e.g. Gad1, 
Tbr1, Gabra5).
We noted that aspects distinguishing many of the cell types appear to overlap, most 
frequently with the myelination signature. For instance, a subset of 35 cells exhibits 
prominent expression of both immune response genes characteristic of microglia as well as 
genes responsible for myelin sheath (Fig. 2). Similarly, myelin-associated expression 
signature is observed for a subset of vascular cells, astrocytes, pyramidal neurons and 
interneurons. These hybrid signatures most likely correspond to cases in which two cells of 
different cell types were captured together (see Supplementary Fig. 2 for the analysis of cell 
type co-occurrence frequencies). The occurrence and functional interpretation of such 
ambiguous cases where a given cell exhibits multiple alternative signatures are apparent 
from PAGODA analysis. In contrast, BackSPIN, as well as other partitioning methods, 
would need to classify such cells based on one of the signatures or isolate them as a separate 
class without exposing their relationship to other groups.
We further evaluated PAGODA performance by re-analyzing datasets that were used to 
present alternative methods of heterogeneity analysis8,11,29, recovering previously identified 
subpopulations and identifying additional biologically-relevant features (Supplementary 
Note 3). In particular, PAGODA’s ability to associate with a given cell multiple, potentially 
independent aspects of transcriptional heterogeneity, allows one to focus on biologically-
relevant subpopulations that may be distinguished by relatively subtle transcriptional 
variation. For instance, in reanalyzing data for mouse CD4+ T that was used to present an 
elegant GP-LVM approach by Buettner et al11, PAGODA successfully recovered Il4ra-Il24 
response and a closely aligned glycolysis aspect in addition to a prominent mitosis-
associated signature, without requiring explicit correction steps. Furthermore, PAGODA 
revealed a prominent subpopulation of cells exhibiting an expression signature typical of 
dendritic cells that was not previously observed.
PAGODA reveals multiple aspects of heterogeneity in mouse NPCs
As heterogeneity amongst NPCs may influence downstream neural diversity, we performed 
Smart-Seq30 on 65 NPCs isolated from the cerebral cortex of 13.5-day embryonic mouse 
brain. The most significant aspect of heterogeneity identified by PAGODA within the 
isolated NPCs reflects gradual induction of the genes associated with neuronal maturation 
and growth (Fig. 3a, top aspect). Approximately half of the cells express Dcx, Sox11, and 
other known markers of neuronal maturation, with the most mature subset expressing genes 
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involved in neuronal maturation and growth cones (Neurod6, Gap43). Such cells maintain 
expression of some progenitor markers (e.g., vimentin) and therefore likely represent 
developing, committed neurons. In contrast, the set of early NPCs exhibits strong M- and S-
phase signatures that are absent from the more mature NPCs, as well as up-regulation of 
genes characteristic of early progenitor state31 (Sox2, Notch2, Hes1) captured by the 
“negative regulation of neuronal differentiation” and “neural tube development” GO 
categories.
Maturation of neuronal progenitors is closely tied to the spatial organization of the 
developing cortex32. We used spatial expression patterns33 of genes differentially expressed 
between the early and maturing NPCs to reconstruct the most likely spatial distribution of 
these cells within the mouse brain (Fig. 3b, Online Methods). As expected, we found early 
NPCs localize close to ventricular zone (VZ). We also used in situ RNA-FISH (Online 
Methods) to examine two genes, Rpa1 and Nnd, of unknown relationship to the embryonic 
cerebral cortex (Fig. 3c). Consistent with their predicted pattern, Rpa1 was most prominent 
in proliferative regions. Ndn localized in the post-mitotic regions (especially the cortical 
plate), as well as rare cells within the subventricular zone (SVZ, Supplementary Fig. 3).
An additional subset of NPCs was distinguished by expression of Eomes, Neurod1, and 
other genes localized to the SVZ region and thought to distinguish basal progenitors31,34. 
The Eomes signature mark cells that express intermediate levels of genes associated with 
neuronal maturation as well as a subset of mature NPCs and subset of early NPCs 
undergoing DNA replication, likely representing neuronally-committed NPCs maturing in 
the SVZ, and dividing basal NPCs, respectively. These dividing cells express notch signaling 
genes (Dll1, Notch2, Mfng) concurrently with Eomes and therefore likely represent nascent 
basal progenitors31.
Two other aspects cut across the main NPC maturation axis. The first is driven by prominent 
expression of Ndn (Fig. 3a). Ndn, initially noted for high expression in mature neurons35, 
has also been shown to be expressed in the VZ36, and to restrict both proliferation and 
apoptosis rates in NPCs36–38. In combination with RNAscope analyses (Supplementary Fig. 
3), we found Ndn to be expressed within a subset of NPCs, approximately a quarter of 
which exhibit pronounced mitotic signatures and are likely localized in the SVZ. The second 
cross-cutting aspect is coordinated expression of Dlx homeodomain transcription factors. 
Dlx genes mark tangentially-migrating NPCs, which originate in the ganglionic eminence 
(GE) and migrate to the cortical areas, giving rise to the GABAergic neurons39,40. The Dlx-
positive cells express other markers of tangentially migrating NPCs, most notably Sp9 and 
Sp8 transcription factors41. Indeed, spatial localization of these cells was predicted to be in 
the GE region, where tangentially-migrating NPCs are expected to originate (Fig. 3b). In 
agreement with earlier observations of such NPCs undergoing mitosis in the cortical 
VZ/SVZ areas, two of ten Dlx-positive NPCs were captured in S-phase and one in M-phase.
To illustrate the methodological advantage of PAGODA, we re-examined our NPC data 
using alternative analysis methods, including PCA, ICA, tSNE12,17, GP-LVM16, and 
BackSPIN9 (Supplementary Figs. 4,5). While none of the methods were able to recover all 
of the identified subpopulations, BackSPIN provided the most compelling results, capturing 
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heterogeneity involving expression of Dlx and Prdx4/Mest. However, the reported clustering 
grouped only some of the cells associated with each signature, illustrating limitations of 
partitioning-based interpretation in a complex biological context.
Discussion
Just like organisms as a whole, individual cells can be classified according to a variety of 
meaningful criteria. For example, tangentially migrating NPCs that, despite being a distinct 
progenitor subtype, go through the same neuronal maturation process as other NPCs. By 
identifying significantly overdispersed gene sets, PAGODA is able to effectively recover 
such complex heterogeneity structures. The potential ambiguity of classification illustrated 
by the NPCs is likely to be present in many biological contexts. In such cases, an optimal 
partition or clustering of cells is unlikely to be fully informative, and the analysis can benefit 
from concurrent interpretation. The gene-set-based approach and interactive interface 
implemented by PAGODA aims to identify and facilitate interpretation of significant 
transcriptional features separating cells within the population.
Methods
Isolation and single-cell RNA-seq of mouse neural progenitor cells (NPC) and astrocytes 
(ASC)s
Single NPCs were isolated from C57BL/6J embryonic day 13.5 cortices for RNA-
sequencing. Timed-pregnant mice were sacrificed by deep anesthesia followed by cervical 
dislocation. The embryos were quickly removed and cortical hemispheres were isolated, 
ganglionic eminences removed, and all pups brains were pooled. All animal protocols were 
approved by the Institutional Animal Care and Use Committee at The Scripps Research 
Institute (La Jolla, CA) and conform to the National Institutes of Health guidelines.
Single cells were isolated by gentle trituration in ice-cold phosphate buffered saline 
containing 2 mM EGTA (PBSE) using P1000 tips with decreasing bore diameter. Cells were 
then filtered through a 40 uM nylon cell strainer and stained with propidium iodide (PI), a 
live-dead stain, and fluorescence activated single cell sorting (FACS) was performed 
selecting for PI negative cells. Samples remained on ice throughout the process and total 
processing time from cervical dislocation to sorting was limited to 2 hours. Single cells were 
sorted directly into cell lysis buffer provided in the Clontech SMARTer® Ultra™ Low RNA 
Kit for Illumina® Sequencing (cat # 634936), and sequencing libraries were generated using 
the manufacturer’s protocol. Resulting libraries were sequenced on the Illumina® HiSeq™ 
2000 sequencing platform.
Gene validation using in situ hybridization with RNA-scope
Mouse E13.5 embryos were removed from timed pregnant mice and prepared according to 
RNAscope instructions for paraffin embedded tissue. RNAscope probes (Advanced Cell 
Diagnostics) were designed by the manufacturer (Cat. # : GINS2 435891, RPA1 435911) 
and sections were processed using RNAscope 2.0 High Definition Reagent Kit - BROWN 
(Cat. #:310035) according to the manufacturer’s instructions. Sections were imaged on a 
Ziess Axioimager at 20× magnification.
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Previously published single-cell RNA-seq data
For the mixture of cultured human neuronal progenitor cells (NPCs) and primary cortical 
samples from Pollen et al29, SRA files for each study were downloaded from the Sequence 
Read Archive (http://www.ncbi.nlm.nih.gov/sra) and converted to FASTQ format using the 
SRA toolkit (v2.3.5). FASTQ files were aligned to the human reference genome (hg19) 
using Tophat (v2.0.10) with Bowtie2 (v2.1.0) and Samtools (v0.1.19). Gene expression 
counts were quantified using HTSeq (v0.5.4). Read counts for the Th2 data by Buettner et 
al11 were downloaded from the supplementary site (http://github.com/PMBio/scLVM/blob/
master/data/Tcell/data_Tcells.Rdata). Read (or UMI) count matrices for other two datasets 
were downloaded from GEO: GSE60361 for Zeisel et al9; GSE59739 for Usoskin et al8.
Fitting single-cell error models—Following the approach described in Kharchenko et 
al27, the read count for a gene g in a cell i was modeled as a mixture of a negative binomial 
(signal) and Poisson (drop-out) components: 
, where  is the probability of 
encountering a drop-out event in a cell i for a gene with population-wide expected 
expression magnitude eg (FPKM); λbg = 0.1 is the low-level signal rate for the dropped-out 
observations; θi(eg) is the negative binomial size parameter (see functional form below); and 
αi is the library size of cell i, as inferred by the fitting procedure. The single-cell error 
models were fitted using the approach described in Kharchenko et al27, with the following 
modifications. 1. Rather than estimating expected expression magnitudes of genes using all 
pairwise comparisons between all other cells, each cell was compared to its k most similar 
cells (based on Pearson linear correlation of genes detected in both cells for any pair of 
cells). The value of k was chosen to approximate the complexity of the dataset (1/3rd of the 
cells for mouse and human NPC datasets, 1/5th for the larger Zeisel et al.9 and Usoskin et 
al.8 datasets). 2. The count dependency on the expected expression magnitude was estimated 
on the linear scale with zero intercept. 3. To improve fit, the drop-out probability was 
modeled using logistic regression on both expression magnitude (log scale) and its square 
value. 4. Instead of fitting a constant value for the negative binomial size parameter θ, it was 
fit as a function of expression magnitude, using the following functional form: log(θ) = a + 
h/(1+10(x−m)*s)r, where x is the expression magnitude (log scale), and a,h,m,s,r are 
parameters of the fit. This functional form provides a more flexible fit than the θ = (a0 + 
a1/x)−1 form used in DESeq42, while allowing for stable asymptotic behavior.
Evaluating overdispersion of individual genes
For each gene, the approach estimates the ratio of observed to expected expression variance 
and the statistical significance of the observed deviation from the expected value. To 
illustrate the rationale, we start with a Poisson approximation. Let  be the number of reads 
observed for a gene g in a cell i. If such reads follow a Poisson distribution with the mean μg 
and variance νg (both equal to some Poisson rate λg), then Fisher’s index of dispersion 
 follows  distribution43. While for the Poisson case νg = μg, for 
negative binomial process, νg = μg + (μg)2/θ, where θ is the size parameter. As θ decreases 
from very high values where the negative binomial is well approximated by a Poisson, Dg 
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diverges from . Analytical adjustments of Dg based on the negative binomial moments 
can improve χ2 approximation44. For more accurate approximation we used a numeric 
correction of the χ2 degrees of freedom, depending on the magnitude of θ, so that 
(Supplementary Note 2, Figure SN2.2).
To account for the possibility of drop-out events, weighted sample variance estimates were 
used, so that: , where  is the 
probability that the measurement in a cell i was not a drop-out event based on the error 
model for cell i, and  is the effective degrees of freedom for the gene g. 
, where eg is the expected expression magnitude of a gene g across the measured 
cells.
Since negative binomial (or NB/Poisson mixture) models do not fully capture the variability 
trends observed in the real scRNA-seq measurements, Dg estimates for the real data can 
systematically deviate from 1. To adjust for this non-centrality, we normalized Dg by its 
transcriptome-wide expectation value , where  models the transcriptome-wide 
dependency of Dg on gene expression magnitude.  estimates were obtained using a 
general additive model (GAM, fit using the mgcv R package) as a smooth function of gene 
expression magnitude eg. To improve smoothness, the GAM fit was performed on the 
corresponding squared coefficient of residual variance (Dg/Eg)2. The fit is performed on all 
of the genes. The P value of overdispersion for a gene g was then be calculated as 
, where  is CDF of χ2 distribution with k degrees of freedom.
To improve stability of the estimates with respect to outliers, a Winsorization procedure45 
was applied to the read count matrix prior to the variance evaluation described above. To 
ensure that the outliers are trimmed in a manner independent of the total cell coverage, the 
Winsorization procedure was applied to the FPM matrix (i.e. normalizing counts by the 
library size), that were then translated back into the integer counts. A trim value of 3 was 
used for all datasets (i.e. observations from the three highest and tree lowest cells for each 
gene were Winsorized).
Weighted PCA and significance of pathway overdispersion—For PCA the data 
was transformed to better approximate the standard normal distribution. Specifically, PCA 
was carried out on a matrix of log-transformed read counts with a pseudocount of 1, 
normalized by the library size: . The values for each gene (matrix row) 
were then scaled so that the weighted variance of a given gene matched the tail probabilities 
of the distribution for a standard normal process: , where QN 
is the quantile function of the standard normal distribution, and varwg(xg) is the weighted 
variance of values xg. As in our previous work
27
, the weight used for the clustering and PCA 
steps included an additional damping coefficient k = 0.9 : , which 
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improved the stability of the subsequent cell clustering for noisy datasets (  is a 
probability of observing  counts in a drop-out event, evaluated from the Poisson PDF).
Weighted PCA was performed for each gene set as described by S. Bailey46, recording first 
(and optionally subsequent) principal components, the magnitude of the eigenvalue (λ1) and 
associated cell scores for each gene set. Statistical significance of the λ1 eigenvalues 
obtained for each gene set (overdispersion P value for a set s, ) was evaluated based on 
the Tracy-Widom F1 distribution
47
 F1(m,ne), where m is the number of genes in a given set 
s, and ne is the effective number of cells, determined to fit the distribution of the randomly 
sampled gene sets (containing the same number of genes as the actual gene sets). The 
presented results used pathways annotated by Gene Ontology (GO), restricting evaluation to 
the GO terms that had between 1000 and 10 annotated genes.
Identification and statistical treatment of de novo gene clusters—Since some 
aspects of transcriptional heterogeneity can be driven by genes that are poorly represented or 
not at all described by the annotated pathways, PAGODA incorporates into the overall 
analysis de novo gene sets that group genes showing correlated patterns of expression across 
the cells measured in a particular dataset. By default, PAGODA, implements a 
straightforward clustering procedure: a hierarchical clustering is performed using Ward 
method (as implemented by the hclust package in R) using a Pearson correlation distance on 
the normalized expression matrix (that is used for the weighted PCA step described above). 
The resulting dendrogram is cut to obtain a pre-defined number of de novo gene clusters (the 
results shown use 150 clusters). As there are many alternative methods for clustering co-
expressed genes, PAGODA implementation provides parameters to use alternative clustering 
procedures.
Since de novo gene clusters are by purposefully selected to contain genes with correlated 
expression profiles, the amount of variance explained by the first principal component 
(magnitude of λ1) will be higher than expected from random matrices, and cannot be 
modeled by the same Trace-Window F1 distribution as previously-annotated gene set. To 
evaluate statistical significance of overdispersion, a background distribution of λ1 was 
generated by performing the same hierarchical clustering and weighted PCA procedure on 
randomized matrices (where cell order was randomized for each gene independently, 100 
randomizations). The λ1 values were normalized relative to Tracy-Widom F1 expectation as 
, where  and  are the mean and variance of λ1 
predicted by the Tracy-Window F1 distribution, and coefficients a and b are determined by 
the linear model . This standardized residual  was modeled using Gumbel 
extreme value distribution, the parameters of which were fit using extRemes package in R. 
The overdispersion P value for each de novo gene set were determined from the tails of that 
distribution. The subsequent procedures treated de novo gene sets and annotated gene sets in 
the same way.
Clustering of redundant heterogeneity patterns—To compile a non-redundant set of 
aspects, the PC cell scores (projections on the eigenvector) from each significantly 
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overdispersed (5% FDR, as estimated by the Benjamini-Hochberg method48) gene set were 
normalized so that the magnitude of their variance corresponds to the tail probability of the 
χ2 distribution: , where  is the quantile function of the χ2 
distribution with n degrees of freedom (n is the number of cells in the dataset). The 
redundant aspects of heterogeneity were reduced in two steps. First, aspects reflecting 
transcriptional variation of the same genes were grouped by evaluating similarity of the 
corresponding gene loading scores in combination with the pattern similarity using the 
following distance measure between gene sets i and j: , 
where cor is Peason linear correlation, li,lj are the loading scores of genes found in both i 
and j sets, and si,sj are the corresponding PC cell scores (dij was set to 1 if there were less 
than 2 genes in common between the gene sets i and j). The distance dij was then used to 
cluster the aspects, using hierarchical clustering with complete-linkage. Clusters separated 
by a distance less than 0.1 were grouped. The cell scores of the grouped aspects were 
determined as cell scores of the first principal component of all aspects within a grouped 
cluster. The second step, aimed at grouping aspects showing similar patterns of cell 
separation, was accomplished by another round of hierarchical clustering using cor(si,sj) 
distance measure with Ward clustering procedure. The similarity threshold for the final 
grouping of similar aspects varied between datasets depending on their complexity (0.5 for 
the human NPC data, 0.95 for the mouse cortical/hippocampal dataset, 0.9 for the T cell and 
the mouse NPC data).
Batch correction—To control for the effect of categorical covariates, such as presence of 
multiple batches in the data, the approach contrasted whole-population and batch-specific 
variance estimates. Specifically, for each gene g, a batch-specific average expression 
magnitude was estimated for each batch b:eg,b. These batch-specific expression estimates 
were then used to obtain batch-adjusted values of Dg,  and kg (Dg,b,  and kg,b 
respectively). To identify genes showing batch-specific variation, the ratio of batch-specific 
and batch-adjusted variance was evaluated as αg = Dg,b/Dg. The residual variance of genes 
showing discrepant batch- and population-specific variance was taken to be 
, and .
The procedure above ensures that batch-specific effects are not reflected in the magnitude of 
the adjusted variance. Batch effects also need to be controlled at the level of expression 
values on which weighted PCA is performed, as batch-specific expression patterns across a 
sufficiently large set of genes can still account for sufficiently high amount of total variance 
to be picked by the PCA analysis. The expression values, , were adjusted 
in two steps, separating drop-out (0 read count) observations from the rest. To adjust for the 
disparity in the frequency of the drop-out observations between batches, the lower bound of 
the zero-count observation fraction (u) was determined for each batch (assuming binomial 
process), and the weights  for each batch were multiplied by min(1,max(u)/Zb), where 
max(u) is the maximum lower bound value amongst batches, and Zb is the fraction of zero-
count observations in a given batch. This procedure ensures that the expected number of 
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zero-count observations is equal amongst all of the batches. The second step adjusted the log 
expression magnitudes of non-zero observations so that the weighted means within each are 
each equal to the population-wide weighted mean. To further control for batch-specific 
effects, weighted PCA was performed using batch-specific centering (i.e. setting weighted 
mean of each batch to 0).
Spatial placement of cell subpopulations—To spatially place neuronal 
subpopulations identified by PAGODA, we used significantly differentially expressed genes 
(absolute corrected Z-score > 1.96) as relative gene expression signatures for each 
subpopulation of interest compared to all other NPCs. In situ hybridization (ISH) data for 
the developing 13.5 day embryonic mouse were downloaded from the Allen Developing 
Mouse Brain Atlas (Website: ©2013 Allen Institute for Brain Science. Allen Developing 
Mouse Brain Atlas: http://developingmouse.brain-map.org) for all available genes 
(n=2,194). ISH data are quantified as gene expression energies, defined as expression 
intensity times expression density, at a grid voxel level. Each voxel corresponds to a 100 µm 
gridding of the original ISH stain images and corresponds to voxel level structure 
annotations according to the accompanying developmental reference atlas ontology. The 3-D 
reference model for the developing 13.5 day embryonic mouse derived from Feulgen-HP 
yellow DNA staining was also downloaded from the Allen Developing Mouse Brain Atlas 
for use as a higher resolution reference image. Energies for genes in each subpopulation's 
gene expression signature with corresponding ISH data available were weighted by 
expression fold change on a log2 scale and summed to constitute a composite overlay of 
gene expression. Background signal and expression detection in regions not annotated as 
part of the mouse embryo in the reference model were removed by applying a minimum 
gene energy level threshold of 8 units. We focused on spatial placements within the 
developing mouse forebrain and thus restricted gene energies to voxels annotated as 
‘forebrain’ or ‘ventricles, forebrain’ in the reference atlas ontology.
In contrast to more complex in situ landmark association methods as presented by Satija et 
al.49 and Achim et al.50, the current method is focused on relative placement of mutually 
exclusive subpopulations. Because of this we are able to take advantage of both upregulated 
and downregulated gene sets in assigning the most likely spatial distribution of each 
identified subpopulation. For example, genes upregulated in the maturing NPCs relative to 
early NPCs can be used as indicators as to where the maturing NPC subpopulation is 
spatially localized. In addition, genes downregulated in maturing NPCs relative to early 
NPCs can also be used as indicators as to where maturing NPCs may be absent. 
Additionally, unlike Satija et al.49, we do not binarize the in situ data since we are 
particularly interested in gradients of expression across voxels or bins in our particular case. 
Likewise, due to the resolution limitations of our in situ data, where each voxel is much 
bigger than one cell, we are unable to precisely map individual cells to single locations as in 
Achim et al's method50.
Implementation and data availability—The PAGODA functions are implemented in 
version 1.99 of scde R package, available at http://pklab.med.harvard.edu/scde/. The source 
code is available on GitHub (https://github.com/hms-dbmi/scde). The spatial mapping of 
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neural cells based on the data generated by the Allen Institute for Brain Science has been 
implemented as a separate R package, called brainmapr, available from GitHub (https://
github.com/hms-dbmi/brainmapr). The scRNA-seq data and gene count matrix for the NPC 
cells is available from Gene Expression Omnibus (GEO) under the GSE76005 accession 
number.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Pathway and gene set overdispersion analysis (PAGODA)
Transcriptional heterogeneity analyzed through the following key steps: 1. Error models are 
fit for each cell to quantify the dependency of amplification noise and drop-out probabilities 
on the expression magnitude27. A model fit for a cell is shown, separating drop-out and 
amplified components, and the 95% confidence envelope of the amplified component; 2. 
The residual expression variance magnitude for each gene is determined relative to the 
transcriptome-wide expectation model (red curve), taking into account the uncertainty in the 
variance estimates of each gene by determining effective degrees of freedom (kg) for the χ2 
distribution; 3. Weighted PCA analysis is performed independently on functionally-
annotated gene sets, as well as de novo gene sets determined based on correlated expression 
in the current dataset; 4. If the amount of variance explained by a principal component of a 
gene set is significantly higher than expected, the gene set is called overdispersed, and the 
cell scores defined by that principal component (coded in orange-green gradient) are 
included as one of the significant aspects of heterogeneity; 5. Redundant aspects that are 
driven by the same genes or show similar patterns of cell separation are grouped to provide 
succinct overview of heterogeneity; 6. A web browser-based interface is used to navigate the 
identified aspects of heterogeneity, associated gene sets and gene expression patterns. 7. 
Depending on the biological question, some of the detected aspects of heterogeneity may be 
deemed artifactual or extraneous, and can be actively controlled for in a subsequent iteration.
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Figure 2. PAGODA analysis of the 3,005 cells from mouse cortex and hippocampus measured by 
Zeisel et al.9
The dendrogram shows the overall clustering of the cells, with the row immediately below 
specifying the group to which each cell was assigned in the original analysis by Zeisel et al. 
The main panel shows the top 9 significant aspects (P < 0.05) of heterogeneity (rows) 
detected by PAGODA based on gene sets defined by GO annotations, with the orange/white/
green gradient indicating high/neutral/low score of a cell with respect to a given aspect. The 
aspect scores are oriented so that high (orange) and low (green) values generally correspond, 
respectively, to increased and decreased expression of the associated gene sets. Row labels 
summarize the key functional annotations of the gene sets in each aspect. Two subsequent 
panels show expression patterns of top-loading genes innate immune response (from the 
aspect distinguishing neuroglia), and myelin sheath (distinguishing oligodendrocytes). A 
population of ~35 cells expressing both signatures is marked by a green bar, and most likely 
represents capture of two associated cells of different type. The bottom panel shows images 
of the microfluidic traps corresponding to some of the dual-signature cells, along with cells 
(leftmost two) exhibiting only the oligodendrocyte signature. Green boxes below the main 
panel highlight cells showing a combination of the oligodendrocyte signature with other cell 
types (numbered 1–5: vascular endothelial, astrocytes, CA1 neurons, Gad1/2 interneurons 
and neuroglia). Detailed composition is available through an interactive online view28.
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Figure 3. Transcriptional heterogeneity of 65 neuronal progenitor cells in embryonic mouse 
cortex
a. Top eight significant (P < 0.01) aspects of heterogeneity are shown, labeled by their 
primary GO category or driving genes. Detailed are available through an online browser28. 
Top aspect tracks induction of neuronal maturation pathways, driving the overall 
subpopulation structure. Mitotic and S-phase signatures in early NPCs account for the next 
two most significant aspects, with the S-phase aspect incorporating closely matching 
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expression patterns of genes responsible for NPC maintenance. Color codes in the top panel 
summarize key subpopulations of NPCs distinguished by the detected heterogeneity aspects.
b. Anatomical placement of the early vs. maturing NPC classes within embryonic brain. In 
situ hybridization signals in E13.5 mouse brain are shown for Tyro3 and Nfasc, with the two 
heatmap rows above showing their expression in the scRNA-seq. Computational prediction 
(third panel) based on the overall transcriptional profile places early NPCs near VZ, and 
maturing ones in SVZ (subventricular zone)/CP regions. In situ images were generated by 
Allen Institute for Brain Science33. The lower panel shows anatomical placement of the Dlx-
expressing NPCs, and in situ images for the associated genes.
c. Validation of genes associated with specific subpopulations by in situ hybridization. 
Coronal E13.5 brain sections labeled using RNAscope probes for Rpa1 (left) and Ndn 
(right). Rpa1 showed high expression in the ventricular (VZ) and sub-ventricular zone 
(SVZ). Ndn, which is marks a distinct subpopulation of both mature and early NPCs, shows 
prominent expression throughout the CP, with rarer high expressing cells in the VZ and SVZ 
(black arrows).
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